HEADER TRANSFERASE/TRANSFERASE INHIBITOR 08-JUL-15 5CF8 TITLE CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH N,N-DICYCLOPROPYL- TITLE 2 10-ETHYL-7-[(3-METHOXYPROPYL)AMINO] -3-METHYL-3,5,8,10- TITLE 3 TETRAAZATRICYCLO[7.3.0.0,6] DODECA-1(9),2(6),4,7,11-PENTAENE-11- TITLE 4 CARBOXAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, UNP RESIDUES 839-1132; COMPND 5 SYNONYM: JANUS KINASE 2,JAK-2; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: JAK2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.S.SACK REVDAT 3 22-NOV-17 5CF8 1 REMARK REVDAT 2 02-SEP-15 5CF8 1 JRNL REVDAT 1 26-AUG-15 5CF8 0 JRNL AUTH H.WAN,G.M.SCHROEDER,A.C.HART,J.INGHRIM,J.GREBINSKI, JRNL AUTH 2 J.S.TOKARSKI,M.V.LORENZI,D.YOU,T.MCDEVITT,B.PENHALLOW, JRNL AUTH 3 R.VUPPUGALLA,Y.ZHANG,X.GU,R.IYER,L.J.LOMBARDO,G.L.TRAINOR, JRNL AUTH 4 S.RUEPP,J.LIPPY,Y.BLAT,J.S.SACK,J.A.KHAN,K.STEFANSKI, JRNL AUTH 5 B.SLECZKA,A.MATHUR,J.H.SUN,M.K.WONG,D.R.WU,P.LI,A.GUPTA, JRNL AUTH 6 P.N.ARUNACHALAM,B.PRAGALATHAN,S.NARAYANAN,N.K C,P.KUPPUSAMY, JRNL AUTH 7 A.V.PURANDARE JRNL TITL DISCOVERY OF A HIGHLY SELECTIVE JAK2 INHIBITOR, BMS-911543, JRNL TITL 2 FOR THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS. JRNL REF ACS MED.CHEM.LETT. V. 6 850 2015 JRNL REFN ISSN 1948-5875 JRNL PMID 26288683 JRNL DOI 10.1021/ACSMEDCHEMLETT.5B00226 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.06 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 80634 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.204 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.050 REMARK 3 FREE R VALUE TEST SET COUNT : 1652 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.85 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.13 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 5478 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2543 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5362 REMARK 3 BIN R VALUE (WORKING SET) : 0.2538 REMARK 3 BIN FREE R VALUE : 0.2765 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 2.12 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 116 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4735 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 64 REMARK 3 SOLVENT ATOMS : 493 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.49 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.18 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.04440 REMARK 3 B22 (A**2) : -2.04440 REMARK 3 B33 (A**2) : 4.08870 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.236 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.106 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.096 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.102 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.094 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.955 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4918 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6653 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1756 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 134 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 760 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4918 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 595 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 6035 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.00 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.44 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.33 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5CF8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-JUL-15. REMARK 100 THE DEPOSITION ID IS D_1000211529. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-FEB-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CLSI REMARK 200 BEAMLINE : 08ID-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9793 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 (DENZO), HKL-2000 REMARK 200 (DENZO) REMARK 200 DATA SCALING SOFTWARE : HKL-2000 (SCALEPACK), HKL-2000 REMARK 200 (SCALEPACK) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 80713 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.05500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 22.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.49400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.95 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM MES BUFFER, 100MM NACL, 28% REMARK 280 (W/V) PEG3350, 2MM DTT, AND 200MM TRI-SODIUM CITRATE, PH 6.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 35.33500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 17.66750 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 53.00250 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 838 REMARK 465 ARG A 839 REMARK 465 ASP A 840 REMARK 465 PRO A 841 REMARK 465 SER A 919 REMARK 465 ALA A 920 REMARK 465 GLY A 921 REMARK 465 ARG A 922 REMARK 465 ARG A 923 REMARK 465 HIS A 1134 REMARK 465 HIS A 1135 REMARK 465 HIS A 1136 REMARK 465 HIS A 1137 REMARK 465 HIS A 1138 REMARK 465 MET B 838 REMARK 465 SER B 919 REMARK 465 ALA B 920 REMARK 465 GLY B 921 REMARK 465 ARG B 922 REMARK 465 ARG B 923 REMARK 465 HIS B 1134 REMARK 465 HIS B 1135 REMARK 465 HIS B 1136 REMARK 465 HIS B 1137 REMARK 465 HIS B 1138 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR A 842 OG1 CG2 REMARK 470 GLN A 843 CG CD OE1 NE2 REMARK 470 ASN A 859 CG OD1 ND2 REMARK 470 GLU A 890 CG CD OE1 OE2 REMARK 470 ARG A 893 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 943 CG CD CE NZ REMARK 470 ARG A 947 CG CD NE CZ NH1 NH2 REMARK 470 LYS A1011 NZ REMARK 470 GLU A1012 CG CD OE1 OE2 REMARK 470 GLU A1015 CG CD OE1 OE2 REMARK 470 LYS A1053 CG CD CE NZ REMARK 470 GLN A1070 CG CD OE1 NE2 REMARK 470 GLN A1072 CG CD OE1 NE2 REMARK 470 LYS B1011 CD CE NZ REMARK 470 LYS B1053 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 859 75.75 32.24 REMARK 500 PHE A 860 -7.68 70.50 REMARK 500 ASP A 976 36.42 -147.52 REMARK 500 GLN A1070 -98.41 -36.33 REMARK 500 TRP A1106 45.49 -88.37 REMARK 500 ASP B 976 34.90 -147.40 REMARK 500 GLU B1015 91.69 60.73 REMARK 500 GLN B1070 -98.07 -36.09 REMARK 500 TRP B1106 41.91 -89.65 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 50V A 4000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 50V B 4000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5CF4 RELATED DB: PDB REMARK 900 RELATED ID: 5CF5 RELATED DB: PDB REMARK 900 RELATED ID: 5CF6 RELATED DB: PDB DBREF 5CF8 A 839 1132 UNP O60674 JAK2_HUMAN 839 1132 DBREF 5CF8 B 839 1132 UNP O60674 JAK2_HUMAN 839 1132 SEQADV 5CF8 MET A 838 UNP O60674 INITIATING METHIONINE SEQADV 5CF8 HIS A 1133 UNP O60674 EXPRESSION TAG SEQADV 5CF8 HIS A 1134 UNP O60674 EXPRESSION TAG SEQADV 5CF8 HIS A 1135 UNP O60674 EXPRESSION TAG SEQADV 5CF8 HIS A 1136 UNP O60674 EXPRESSION TAG SEQADV 5CF8 HIS A 1137 UNP O60674 EXPRESSION TAG SEQADV 5CF8 HIS A 1138 UNP O60674 EXPRESSION TAG SEQADV 5CF8 MET B 838 UNP O60674 INITIATING METHIONINE SEQADV 5CF8 HIS B 1133 UNP O60674 EXPRESSION TAG SEQADV 5CF8 HIS B 1134 UNP O60674 EXPRESSION TAG SEQADV 5CF8 HIS B 1135 UNP O60674 EXPRESSION TAG SEQADV 5CF8 HIS B 1136 UNP O60674 EXPRESSION TAG SEQADV 5CF8 HIS B 1137 UNP O60674 EXPRESSION TAG SEQADV 5CF8 HIS B 1138 UNP O60674 EXPRESSION TAG SEQRES 1 A 301 MET ARG ASP PRO THR GLN PHE GLU GLU ARG HIS LEU LYS SEQRES 2 A 301 PHE LEU GLN GLN LEU GLY LYS GLY ASN PHE GLY SER VAL SEQRES 3 A 301 GLU MET CYS ARG TYR ASP PRO LEU GLN ASP ASN THR GLY SEQRES 4 A 301 GLU VAL VAL ALA VAL LYS LYS LEU GLN HIS SER THR GLU SEQRES 5 A 301 GLU HIS LEU ARG ASP PHE GLU ARG GLU ILE GLU ILE LEU SEQRES 6 A 301 LYS SER LEU GLN HIS ASP ASN ILE VAL LYS TYR LYS GLY SEQRES 7 A 301 VAL CYS TYR SER ALA GLY ARG ARG ASN LEU LYS LEU ILE SEQRES 8 A 301 MET GLU TYR LEU PRO TYR GLY SER LEU ARG ASP TYR LEU SEQRES 9 A 301 GLN LYS HIS LYS GLU ARG ILE ASP HIS ILE LYS LEU LEU SEQRES 10 A 301 GLN TYR THR SER GLN ILE CYS LYS GLY MET GLU TYR LEU SEQRES 11 A 301 GLY THR LYS ARG TYR ILE HIS ARG ASP LEU ALA THR ARG SEQRES 12 A 301 ASN ILE LEU VAL GLU ASN GLU ASN ARG VAL LYS ILE GLY SEQRES 13 A 301 ASP PHE GLY LEU THR LYS VAL LEU PRO GLN ASP LYS GLU SEQRES 14 A 301 PTR PTR LYS VAL LYS GLU PRO GLY GLU SER PRO ILE PHE SEQRES 15 A 301 TRP TYR ALA PRO GLU SER LEU THR GLU SER LYS PHE SER SEQRES 16 A 301 VAL ALA SER ASP VAL TRP SER PHE GLY VAL VAL LEU TYR SEQRES 17 A 301 GLU LEU PHE THR TYR ILE GLU LYS SER LYS SER PRO PRO SEQRES 18 A 301 ALA GLU PHE MET ARG MET ILE GLY ASN ASP LYS GLN GLY SEQRES 19 A 301 GLN MET ILE VAL PHE HIS LEU ILE GLU LEU LEU LYS ASN SEQRES 20 A 301 ASN GLY ARG LEU PRO ARG PRO ASP GLY CYS PRO ASP GLU SEQRES 21 A 301 ILE TYR MET ILE MET THR GLU CYS TRP ASN ASN ASN VAL SEQRES 22 A 301 ASN GLN ARG PRO SER PHE ARG ASP LEU ALA LEU ARG VAL SEQRES 23 A 301 ASP GLN ILE ARG ASP ASN MET ALA GLY HIS HIS HIS HIS SEQRES 24 A 301 HIS HIS SEQRES 1 B 301 MET ARG ASP PRO THR GLN PHE GLU GLU ARG HIS LEU LYS SEQRES 2 B 301 PHE LEU GLN GLN LEU GLY LYS GLY ASN PHE GLY SER VAL SEQRES 3 B 301 GLU MET CYS ARG TYR ASP PRO LEU GLN ASP ASN THR GLY SEQRES 4 B 301 GLU VAL VAL ALA VAL LYS LYS LEU GLN HIS SER THR GLU SEQRES 5 B 301 GLU HIS LEU ARG ASP PHE GLU ARG GLU ILE GLU ILE LEU SEQRES 6 B 301 LYS SER LEU GLN HIS ASP ASN ILE VAL LYS TYR LYS GLY SEQRES 7 B 301 VAL CYS TYR SER ALA GLY ARG ARG ASN LEU LYS LEU ILE SEQRES 8 B 301 MET GLU TYR LEU PRO TYR GLY SER LEU ARG ASP TYR LEU SEQRES 9 B 301 GLN LYS HIS LYS GLU ARG ILE ASP HIS ILE LYS LEU LEU SEQRES 10 B 301 GLN TYR THR SER GLN ILE CYS LYS GLY MET GLU TYR LEU SEQRES 11 B 301 GLY THR LYS ARG TYR ILE HIS ARG ASP LEU ALA THR ARG SEQRES 12 B 301 ASN ILE LEU VAL GLU ASN GLU ASN ARG VAL LYS ILE GLY SEQRES 13 B 301 ASP PHE GLY LEU THR LYS VAL LEU PRO GLN ASP LYS GLU SEQRES 14 B 301 PTR PTR LYS VAL LYS GLU PRO GLY GLU SER PRO ILE PHE SEQRES 15 B 301 TRP TYR ALA PRO GLU SER LEU THR GLU SER LYS PHE SER SEQRES 16 B 301 VAL ALA SER ASP VAL TRP SER PHE GLY VAL VAL LEU TYR SEQRES 17 B 301 GLU LEU PHE THR TYR ILE GLU LYS SER LYS SER PRO PRO SEQRES 18 B 301 ALA GLU PHE MET ARG MET ILE GLY ASN ASP LYS GLN GLY SEQRES 19 B 301 GLN MET ILE VAL PHE HIS LEU ILE GLU LEU LEU LYS ASN SEQRES 20 B 301 ASN GLY ARG LEU PRO ARG PRO ASP GLY CYS PRO ASP GLU SEQRES 21 B 301 ILE TYR MET ILE MET THR GLU CYS TRP ASN ASN ASN VAL SEQRES 22 B 301 ASN GLN ARG PRO SER PHE ARG ASP LEU ALA LEU ARG VAL SEQRES 23 B 301 ASP GLN ILE ARG ASP ASN MET ALA GLY HIS HIS HIS HIS SEQRES 24 B 301 HIS HIS MODRES 5CF8 PTR A 1007 TYR MODIFIED RESIDUE MODRES 5CF8 PTR A 1008 TYR MODIFIED RESIDUE MODRES 5CF8 PTR B 1007 TYR MODIFIED RESIDUE MODRES 5CF8 PTR B 1008 TYR MODIFIED RESIDUE HET PTR A1007 16 HET PTR A1008 16 HET PTR B1007 16 HET PTR B1008 16 HET 50V A4000 32 HET 50V B4000 32 HETNAM PTR O-PHOSPHOTYROSINE HETNAM 50V N,N-DICYCLOPROPYL-4-[(1,5-DIMETHYL-1H-PYRAZOL-3-YL) HETNAM 2 50V AMINO]-6-ETHYL-1-METHYL-1,6-DIHYDROIMIDAZO[4,5- HETNAM 3 50V D]PYRROLO[2,3-B]PYRIDINE-7-CARBOXAMIDE HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 4(C9 H12 N O6 P) FORMUL 3 50V 2(C23 H28 N8 O) FORMUL 5 HOH *493(H2 O) HELIX 1 AA1 GLU A 845 ARG A 847 5 3 HELIX 2 AA2 THR A 888 SER A 904 1 17 HELIX 3 AA3 SER A 936 HIS A 944 1 9 HELIX 4 AA4 ASP A 949 LYS A 970 1 22 HELIX 5 AA5 ALA A 978 ARG A 980 5 3 HELIX 6 AA6 PRO A 1017 TYR A 1021 5 5 HELIX 7 AA7 ALA A 1022 SER A 1029 1 8 HELIX 8 AA8 SER A 1032 THR A 1049 1 18 HELIX 9 AA9 GLU A 1052 LYS A 1055 5 4 HELIX 10 AB1 SER A 1056 GLY A 1066 1 11 HELIX 11 AB2 GLY A 1071 ASN A 1084 1 14 HELIX 12 AB3 PRO A 1095 TRP A 1106 1 12 HELIX 13 AB4 ASN A 1109 ARG A 1113 5 5 HELIX 14 AB5 SER A 1115 GLY A 1132 1 18 HELIX 15 AB6 GLU B 845 ARG B 847 5 3 HELIX 16 AB7 THR B 888 SER B 904 1 17 HELIX 17 AB8 SER B 936 HIS B 944 1 9 HELIX 18 AB9 ASP B 949 LYS B 970 1 22 HELIX 19 AC1 ALA B 978 ARG B 980 5 3 HELIX 20 AC2 PRO B 1017 TYR B 1021 5 5 HELIX 21 AC3 ALA B 1022 SER B 1029 1 8 HELIX 22 AC4 SER B 1032 THR B 1049 1 18 HELIX 23 AC5 GLU B 1052 LYS B 1055 5 4 HELIX 24 AC6 SER B 1056 GLY B 1066 1 11 HELIX 25 AC7 GLY B 1071 ASN B 1084 1 14 HELIX 26 AC8 PRO B 1095 TRP B 1106 1 12 HELIX 27 AC9 ASN B 1109 ARG B 1113 5 5 HELIX 28 AD1 SER B 1115 GLY B 1132 1 18 SHEET 1 AA1 5 LEU A 849 GLY A 858 0 SHEET 2 AA1 5 GLY A 861 TYR A 868 -1 O MET A 865 N GLN A 853 SHEET 3 AA1 5 VAL A 878 LEU A 884 -1 O VAL A 879 N CYS A 866 SHEET 4 AA1 5 LYS A 926 GLU A 930 -1 O MET A 929 N ALA A 880 SHEET 5 AA1 5 TYR A 913 CYS A 917 -1 N GLY A 915 O ILE A 928 SHEET 1 AA2 2 TYR A 972 ILE A 973 0 SHEET 2 AA2 2 LYS A 999 VAL A1000 -1 O LYS A 999 N ILE A 973 SHEET 1 AA3 2 ILE A 982 ASN A 986 0 SHEET 2 AA3 2 ARG A 989 ILE A 992 -1 O LYS A 991 N LEU A 983 SHEET 1 AA4 2 PTR A1008 LYS A1009 0 SHEET 2 AA4 2 LYS A1030 PHE A1031 -1 O PHE A1031 N PTR A1008 SHEET 1 AA5 6 GLN B 843 PHE B 844 0 SHEET 2 AA5 6 TYR B 913 CYS B 917 1 O VAL B 916 N PHE B 844 SHEET 3 AA5 6 LYS B 926 GLU B 930 -1 O ILE B 928 N GLY B 915 SHEET 4 AA5 6 VAL B 878 LEU B 884 -1 N ALA B 880 O MET B 929 SHEET 5 AA5 6 GLY B 861 TYR B 868 -1 N CYS B 866 O VAL B 879 SHEET 6 AA5 6 LEU B 849 LYS B 857 -1 N GLN B 853 O MET B 865 SHEET 1 AA6 2 TYR B 972 ILE B 973 0 SHEET 2 AA6 2 LYS B 999 VAL B1000 -1 O LYS B 999 N ILE B 973 SHEET 1 AA7 2 ILE B 982 ASN B 986 0 SHEET 2 AA7 2 ARG B 989 ILE B 992 -1 O LYS B 991 N LEU B 983 SHEET 1 AA8 2 PTR B1008 LYS B1009 0 SHEET 2 AA8 2 LYS B1030 PHE B1031 -1 O PHE B1031 N PTR B1008 LINK C GLU A1006 N PTR A1007 1555 1555 1.33 LINK C PTR A1007 N PTR A1008 1555 1555 1.33 LINK C PTR A1008 N LYS A1009 1555 1555 1.34 LINK C GLU B1006 N PTR B1007 1555 1555 1.33 LINK C PTR B1007 N PTR B1008 1555 1555 1.34 LINK C PTR B1008 N LYS B1009 1555 1555 1.35 SITE 1 AC1 17 LEU A 855 GLY A 856 LYS A 857 GLY A 858 SITE 2 AC1 17 VAL A 863 ALA A 880 GLU A 930 TYR A 931 SITE 3 AC1 17 LEU A 932 PRO A 933 GLY A 935 ARG A 980 SITE 4 AC1 17 ASN A 981 LEU A 983 ASP A 994 HOH A4158 SITE 5 AC1 17 GLU B 987 SITE 1 AC2 13 LEU B 855 GLY B 856 ALA B 880 GLU B 930 SITE 2 AC2 13 TYR B 931 LEU B 932 PRO B 933 GLY B 935 SITE 3 AC2 13 ARG B 980 ASN B 981 LEU B 983 ASP B 994 SITE 4 AC2 13 HOH B4266 CRYST1 112.160 112.160 70.670 90.00 90.00 90.00 P 41 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008916 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008916 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014150 0.00000